OncoTraQ offers a broad array of secondary support to keep our clients on the cutting edge of the changing development and commercial landscape across oncology.
Interactive analytics and monitoring drive quick analysis and strategic decision-making based on a customized dashboard with key trends rapidly analyzed and presented in a easily digestible format.
OncoTraQ provides living databases to facilitate understanding of key trends across the complex oncology landscape including immuno-oncology and gene therapy.
Around-the-Clock Secondary Monitoring
with tailored news summaries and trend reports
Oncology KOL Database
PulseTraQ Oncology Monitoring
Module 1: Secondary News and Alerts
OncoTraQ’s global footprint enables us to monitor ‘around the clock’ for key updates and changes in the landscape
Customized News Summaries
Eliminate ‘data dumps’ by tailoring your secondary news flow based on your needs
Key news summarized for senior management based on your priorities in a customized format
Available SAI MedPartners Oncology Expert Support
Our Team of Oncology Experts is available to provide tailored insights, implications, and analysis for your team
Module 2: Competitor Profiles (Product and Company)
Summary of key oncology portfolio initiatives and investments
Focus on profiles of priority tumor types
Trend analysis for combination approaches and strategies
Summary of company platform technology investments
Deal Tracker: Tracking oncology Mergers, Acquisitions, and Licensing deals
Module 3: Conference Planning and Coverage
Satellite industry-sponsored symposia can also be included in planners if desired
Conference timelines will also be provided to help you and your team plan for success (including: abstract submission deadlines, abstract title release date, abstract release date, late-breaking abstracts, and conference dates)
Our SAI team is available to cover conferences. This can include pictures of all relevant oral and poster presentations, satellite symposia, and promotional materials and key messaging, summaries of key data presentations and trends, conference trends including share of voice assessment as well as optional catered strategic support.
Interactive Competitor Trial and Launch Timelines
Sortable by asset, phase, sponsor, pivotal, patient segment/indication
- Trial design: Endpoints, enrollment target, timing
- Summary of current global knowledge of the trial
- Key assumptions driving timelines
- Direct links to summaries of intelligence gathered by your field teams or by SAI MedPartners
Interactive Competitor Pipeline Summary:
Oncology Social Media Monitoring
Is the community skeptical about the new technology?
How is pricing of certain agents being discussed?
What are Key Opinion Leaders thinking about the newest data?
Track the Evolution of Each of These Complex Oncology Landscapes in Real-Time
Cell and Gene Therapy Landscape
Searchable and sortable by:
Vectors, Construct, Targets, Cell subset, ROA, Company, most advanced phase of development
Product and Company Profiles
- Key oncology portfolio initiatives and investments
- Priority tumors
- Combination approaches
- Platform investments
- Partnerships and collaborations
Checkpoint Inhibitor Landscape
(Monotherapy and Combination)
Next-Generation Immunotherapy Landscape
Including resources and links
summarizing the current state of patient selection and biomarker development across the landscape
Includes each of the below categories:
Examples: LAG-3, TIM-3, TIGIT
Examples: GITR, 4-1BB, OX-40
Adoptive Cell Therapy
Examples: CAR-T, TILs, NK cells
NK/Myeloid Cell Targeting
Examples: CD47, SIRPα, NKG2A
Examples: T-VEC, AXAL, Cavatak
Examples: ZW-25, Blincyto, Anti-FAP/IL-2
Examples: NKTR-214, pegilodecakin
Microenvironment Targeted Agents
Examples: PI3Kγ, VEGF, IDO, STING
Examples: NY-ESO, Neoantigen vaccine
KOL Database with Validated Top-Tier Oncologists
Identified through a comprehensive search of the leading conferences, journals, guidelines, and educational programs
Searchable and Sortable by the Following Features:
Celebrity status: Celebrity, Superstar, or Rising Star
Disclosures/Conflicts of interest
Our sister company, SAI MedPartners, can also provide support through blinded KOL interviews and double-blind real-time virtual advisory boards at conferences
Ready to Try TheraTraQ?
Tell us a little about your company so we can assess your needs and provide the best solution for you...